These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 8709130

  • 1. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics.
    Bolós J, Gubert S, Anglada L, Planas JM, Burgarolas C, Castelló JM, Sacristán A, Ortiz JA.
    J Med Chem; 1996 Jul 19; 39(15):2962-70. PubMed ID: 8709130
    [Abstract] [Full Text] [Related]

  • 2. 7-[3-(1-piperidinyl)propoxy]chromenones as potential atypical antipsychotics. 2. Pharmacological profile of 7-[3-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)-piperidin-1-yl]propoxy]-3-(hydroxymeth yl)chromen -4-one (abaperidone, FI-8602).
    Bolós J, Anglada L, Gubert S, Planas JM, Agut J, Príncep M, De la Fuente N, Sacristán A, Ortiz JA.
    J Med Chem; 1998 Dec 31; 41(27):5402-9. PubMed ID: 9876110
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and biological activity of picobenzide (3,5-dimethyl-N-(pyridin-4-ylmethyl)benzamide) analogues as potential antipsychotic agents.
    Gradillas A, López B, Braña MF, Sancho I, Pérez-García C, Alguacil LF.
    Arzneimittelforschung; 2005 Dec 31; 55(12):725-9. PubMed ID: 16430025
    [Abstract] [Full Text] [Related]

  • 4. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
    Campiani G, Butini S, Fattorusso C, Catalanotti B, Gemma S, Nacci V, Morelli E, Cagnotto A, Mereghetti I, Mennini T, Carli M, Minetti P, Di Cesare MA, Mastroianni D, Scafetta N, Galletti B, Stasi MA, Castorina M, Pacifici L, Vertechy M, Di Serio S, Ghirardi O, Tinti O, Carminati P.
    J Med Chem; 2004 Jan 01; 47(1):143-57. PubMed ID: 14695828
    [Abstract] [Full Text] [Related]

  • 5. QF2004B, a potential antipsychotic butyrophenone derivative with similar pharmacological properties to clozapine.
    Brea J, Castro M, Loza MI, Masaguer CF, Raviña E, Dezi C, Pastor M, Sanz F, Cabrero-Castel A, Galán-Rodríguez B, Fernández-Espejo E, Maldonado R, Robledo P.
    Neuropharmacology; 2006 Aug 01; 51(2):251-62. PubMed ID: 16697427
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
    Perrault G, Depoortere R, Morel E, Sanger DJ, Scatton B.
    J Pharmacol Exp Ther; 1997 Jan 01; 280(1):73-82. PubMed ID: 8996184
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis, and evaluation of the antipsychotic potential of orally bioavailable neurotensin (8-13) analogues containing non-natural arginine and lysine residues.
    Hadden MK, Orwig KS, Kokko KP, Mazella J, Dix TA.
    Neuropharmacology; 2005 Dec 01; 49(8):1149-59. PubMed ID: 16095636
    [Abstract] [Full Text] [Related]

  • 10. Neuroleptic activity of 10-(4-methyl-1-piperazinyl)-thieno[3,2-b] [1,5]benzoxazepine and benzothiazepine derivatives.
    Corral C, Lissavetzky J, Valdeolmillos A, Bravo L, Darias V, Sánchez Mateo C.
    Arzneimittelforschung; 1992 Jul 01; 42(7):896-900. PubMed ID: 1358080
    [Abstract] [Full Text] [Related]

  • 11. New (sulfonyloxy)piperazinyldibenzazepines as potential atypical antipsychotics: chemistry and pharmacological evaluation.
    Liao Y, Venhuis BJ, Rodenhuis N, Timmerman W, Wikström H, Meier E, Bartoszyk GD, Böttcher H, Seyfried CA, Sundell S.
    J Med Chem; 1999 Jun 17; 42(12):2235-44. PubMed ID: 10377229
    [Abstract] [Full Text] [Related]

  • 12. L-745,870, a subtype selective dopamine D4 receptor antagonist, does not exhibit a neuroleptic-like profile in rodent behavioral tests.
    Bristow LJ, Collinson N, Cook GP, Curtis N, Freedman SB, Kulagowski JJ, Leeson PD, Patel S, Ragan CI, Ridgill M, Saywell KL, Tricklebank MD.
    J Pharmacol Exp Ther; 1997 Dec 17; 283(3):1256-63. PubMed ID: 9400001
    [Abstract] [Full Text] [Related]

  • 13. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
    Marquis KL, Sabb AL, Logue SF, Brennan JA, Piesla MJ, Comery TA, Grauer SM, Ashby CR, Nguyen HQ, Dawson LA, Barrett JE, Stack G, Meltzer HY, Harrison BL, Rosenzweig-Lipson S.
    J Pharmacol Exp Ther; 2007 Jan 17; 320(1):486-96. PubMed ID: 17038512
    [Abstract] [Full Text] [Related]

  • 14. Psychotropic agents. 3. 4-(4-Substituted piperidinyl)-1-(4-fluorophenyl)-1-butanones with potent neuroleptic activity.
    Sato M, Arimoto M, Ueno K, Kojima H, Yamasaki T, Sakurai T, Kasahara A.
    J Med Chem; 1978 Nov 17; 21(11):1116-20. PubMed ID: 31476
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological profiles in rats of novel antipsychotics with combined dopamine D2/serotonin 5-HT1A activity: comparison with typical and atypical conventional antipsychotics.
    Bardin L, Auclair A, Kleven MS, Prinssen EP, Koek W, Newman-Tancredi A, Depoortère R.
    Behav Pharmacol; 2007 Mar 17; 18(2):103-18. PubMed ID: 17351418
    [Abstract] [Full Text] [Related]

  • 16. Neuropsychopharmacological profile of remoxipride in comparison with clozapine.
    Skuza G, Rogóz Z, Wieczorek A.
    Pol J Pharmacol; 1997 Mar 17; 49(1):5-15. PubMed ID: 9431546
    [Abstract] [Full Text] [Related]

  • 17. 6-(alkylamino)-9-alkylpurines. A new class of potential antipsychotic agents.
    Kelley JL, Bullock RM, Krochmal MP, McLean EW, Linn JA, Durcan MJ, Cooper BR.
    J Med Chem; 1997 Sep 26; 40(20):3207-16. PubMed ID: 9379440
    [Abstract] [Full Text] [Related]

  • 18. 3-substituted-1,2-benzisoxazoles: novel antipsychotic agents.
    Davis L, Effland RC, Klein JT, Dunn RW, Geyer HM, Petko WW.
    Drug Des Discov; 1992 Feb 26; 8(3):225-40. PubMed ID: 1356026
    [Abstract] [Full Text] [Related]

  • 19. S18327 (1-[2-[4-(6-fluoro-1, 2-benzisoxazol-3-yl)piperid-1-yl]ethyl]3-phenyl imidazolin-2-one), a novel, potential antipsychotic displaying marked antagonist properties at alpha(1)- and alpha(2)-adrenergic receptors: II. Functional profile and a multiparametric comparison with haloperidol, clozapine, and 11 other antipsychotic agents.
    Millan MJ, Brocco M, Rivet JM, Audinot V, Newman-Tancredi A, Maiofiss L, Queriaux S, Despaux N, Peglion JL, Dekeyne A.
    J Pharmacol Exp Ther; 2000 Jan 26; 292(1):54-66. PubMed ID: 10604931
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological studies on timiperone, a new neuroleptic drug. Part I: Behavior effects.
    Yamasaki T, Kojima H, Sakurai T, Kasahara A, Watanabe S, Fujiwara M, Ueki S.
    Arzneimittelforschung; 1981 Jan 26; 31(4):701-7. PubMed ID: 6113833
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.